Home › NDC Lookup › RxCUI directory › RxCUI 309305

Ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension — RxCUI 309305

RxNorm drug concept · Semantic clinical drug
RxCUI 309305 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309305
Official nameCiprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asciprofloxacin 0.2 % / hydrocortisone 1 % Otic Suspension
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)17,777 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ciprofloxacin Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • These drops are an antibiotic specifically for bacterial eye infections. They're approved to treat two conditions: bacterial conjunctivitis — which most people call pink eye — and...
  • What exactly does ciprofloxacin eye drops treat?
  • Yes, especially for corneal ulcers — the schedule is intentionally intensive at the start to get the infection under control quickly. You'll be using drops very frequently the firs...
  • The dosing schedule looks really complicated — do I really need to use them that often?
📖 Read our full Ciprofloxacin Ophthalmic guide →

🕸️ Concept Web — How Ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension RxCUI 309305

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Ciprofloxacin 2551
    • Hydrocortisone 5492
    • Ciprofloxacin / hydrocortisone 465711
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cipro HC 216063
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ciprofloxacin / hydrocortisone Otic Suspension 374589
    • Ciprofloxacin / hydrocortisone Otic Product 1152114
    • Ciprofloxacin / hydrocortisone Otic Suspension [Cipro HC] 366134
    • Cipro HC Otic Product 1170896
    • Otic Suspension 316974
    • Otic Product 1151134
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ciprofloxacin 2 MG/ML SCDC · 315685
  • Hydrocortisone 10 MG/ML SCDC · 316057
  • Ciprofloxacin / hydrocortisone Otic Suspension SCDF · 374589
  • Ciprofloxacin / hydrocortisone Otic Product SCDG · 1152114

Brand-Name Concepts

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 309305 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00713-0851-09 1 BOTTLE in 1 CARTON (0713-0851-09) / 10 mL in 1 BOTTLE ciprofloxacin hydrochloride and hydrocortisone Cosette Pharmaceuticals, Inc. 2025-12-04
50090-6043-00 10 mL in 1 BOTTLE (50090-6043-0) CIPRO HC A-S Medication Solutions 2022-07-15
50090-7631-00 1 BOTTLE in 1 CARTON (50090-7631-0) / 10 mL in 1 BOTTLE CIPRO HC A-S Medication Solutions 2025-08-14
66758-0087-70 1 BOTTLE in 1 CARTON (66758-087-70) / 10 mL in 1 BOTTLE CIPRO HC Sandoz Inc 2024-11-08
76420-0273-10 10 mL in 1 BOTTLE (76420-273-10) CIPRO HC Asclemed USA, Inc. 2022-09-07
Observed labelers: A-S Medication Solutions (2) · Asclemed USA, Inc. (1) · Cosette Pharmaceuticals, Inc. (1) · Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$31.3030
Range $27.7397–$34.8663 · middle 50% $29.5214–$33.0847 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.